ARCALIS is pleased to announce that it will be exhibiting at INTERPHEX Week Tokyo 2026 to be held at Makuhari Messe from May 20 (Wednesday) to May 22 (Friday), 2026.

In addition, Hamid Trimech, Head of the Business Development of ARCALIS, is scheduled to speak at an Exhibitor Seminar during the event. We sincerely look forward to welcoming you at our booth.

Official Website：INTERPHEX Week Tokyo / Regenerative Medicine Expo Tokyo

Booth Information

Dates：May 20 (Wednesday) – May 22 (Friday), 2026

Venue ： Makuhari Messe, Hall 3　The 1st CMO/CDMO EXPO

Booth No. ：16-46

Presentation Information

Exhibitor Seminar：インターフェックスWeek／再生医療EXPO東京 – Session Directory – 20th May

Session Title： mRNA Technology Transfer: Best Practices and Key Considerations in CDMO Collaboration

Session Abstract：CDMOs are critical players in the biotech landscape. With the arrival of new modalities such as mRNA, CDMOs have a greater role to play in bringing new medicines from R&D to GMP manufacturing. ARCALIS, Inc., founded in 2021 during the COVID-19 pandemic, was established to offer end to end mRNA CDMO services from mRNA DS to LNP bulk and fill and finish. After completion of its DS facility in Minamisoma, Fukushima Prefecture in July 2023, ARCALIS, Inc. transferred from the US to Japan, Kostaive, the world’s first approved sa mRNA vaccine, in a record time: 12 months from IQOQ to PPQ completion. In February 2026, ARCALIS inaugurated its Drug Product Facility enabling it to fill aseptic vials and lyophilized drug product. Drawing on its experience in mRNA vaccines, ARCALIS is now supporting pre clinical programs to move into GMP manufacturing for First In Human trials. Hamid, who led the design and construction of the DS and DP facility as well as the technology transfer of both mRNA and LNP, will share his experience and key considerations on CDMO management, technology transfer and mRNA / LNP manufacturing.

Date & Time： May 20 (Wednesday), 2026　11:40 – 12:50

Venue： Exhibitors’ Presentation Venue 5 / CDMO Forum Venue 2 (Hall 3)

Speaker：Hamid Trimech, Head of Business Development at ARCALIS, Inc.